Clinical Trial

Mindfulness Psychoeducation for Schizophrenia

Completed
View on ClinicalTrials.gov →
Summary
This study aims to examine the effects of a mindfulness-based psychoeducation program on mindfulness levels and treatment adherence among individuals diagnosed with schizophrenia. Schizophrenia is a chronic psychiatric disorder that affects thinking, emotions, and behavior, and difficulties in adhering to prescribed treatments are commonly observed. Poor treatment adherence is associated with relapse, increased hospitalization, and reduced overall functioning. This randomized controlled study includes 40 patients assigned to either an experimental group or a control group. The experimental group receives a structured mindfulness-based psychoeducation program, while the control group receives treatment as usual without any additional intervention. Assessments are conducted before and after the intervention using a Personal Information Form, a Mindfulness Scale, and the Morisky Medication Adherence Scale.
Trial Details
NCT Number NCT07310615
Lead Sponsor Ömer USLU
Conditions Schizophrenia
Enrollment 40 participants
Start Date 2024-12-25
Primary Completion 2025-07-13 (estimated)
Study Completion 2025-09-13 (estimated)
Updated on ClinicalTrials.gov 2025-12-30